How to setup a successful transplant program for hemoglobinopathies in developing countries: The Cure2Children approach
Hematopoietic stem cell transplantation (HSCT) remains the only established definitive cure for severe hemoglobinopathies, such as sickle cell disease (SCD) and thalassemia—the most prevalent life-threatening non-communicable disease of childhood globally. HSCT can not only cure over 85% of children...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | Hematology/Oncology and Stem Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1658387620300339 |